Evidence map›Paper›PMID 30232331›Full record

ArticleExperimental & molecular medicine2018

Author Correction: Rab25 augments cancer cell invasiveness through a β1 integrin/EGFR/VEGF-A/Snail signaling axis and expression of fascin.

Bo Young Jeong, Kyung Hwa Cho, Kang Jin Jeong, Yun-Yong Park, Jin Man Kim, Sun Young Rha, Chang Gyo Park, Gordon B Mills, Jae-Ho Cheong, Hoi Young Lee

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Experimental & molecular medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 7 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Bo Young Jeong *Department of Pharmacology, College of Medicine, Konyang University, Daejeon, Korea.
Kyung Hwa Cho *Department of Pharmacology, College of Medicine, Konyang University, Daejeon, Korea.
Kang Jin JeongDepartment of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Yun-Yong ParkDepartment of Convergence Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Jin Man KimCancer Research Institute, Regional Cancer Center and Infection Signaling Network Research Center, Chungnam National University School of Medicine, Daejeon, Korea.
Sun Young RhaDivison of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
Chang Gyo ParkDepartment of Pharmacology, College of Medicine, Konyang University, Daejeon, Korea.
Gordon B MillsDepartment of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Jae-Ho CheongDepartment of Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. jhcheong@yuhs.ac.
Hoi Young LeeDepartment of Pharmacology, College of Medicine, Konyang University, Daejeon, Korea. hoi@konyang.ac.kr.
Konyang University · KRThe University of Texas MD Anderson Cancer Center · USChungnam National University · KRSeverance Hospital · KRUlsan College · KRYonsei University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

After online publication of this article, the authors noticed an error in the Figure 4c and Figure 5c section.

Identifiers

PMID30232331
PMCPMC6145867
OpenAlexW2891932638

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.